FDA 483 - Amplion Clinical Communications, Inc. - September 04, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Amplion Clinical Communications, Inc. in Nashville, TN, revealed significant deficiencies across multiple quality system areas related to their Amplion Care Assurance Nurse Call System. The firm was cited for inadequate risk analysis, poor documentation of corrective and preventive actions, and failures in establishing procedures for design changes, design transfer, and design output. Additionally, issues were noted in complaint handling and the lack of Unique Device Identifier (UDI) implementation.
- Person
ID · b54e3be6-5d11-49b1-b39e-69cbf9f2b3c6